Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

  • Pages: 49
  • Published: August 2017
  • Report Code: F1D1D45B-610E-4D6E-98C2-C00A7C54B17F
  • Add to Saved List

Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Alexion Pharmaceuticals (Alexion or 'the company') is a biopharmaceutical company engaged in the innovation, development and commercialization of life-transforming therapeutic products. The company primarily operates in the US, Europe and Asia Pacific. It is headquartered in Cheshire, Connecticut, and employed 2,924 people as on December 31, 2015.

Scope

- Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Alexion Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Alexion Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Alexion Pharmaceuticals, Inc.: Company Overview

Alexion Pharmaceuticals, Inc.: Overview and Key Facts

Alexion Pharmaceuticals, Inc.: Overview

Alexion Pharmaceuticals, Inc.: Key ...

Table of Contents

Company Snapshot

Alexion Pharmaceuticals, Inc.: Company Overview

Alexion Pharmaceuticals, Inc.: Overview and Key Facts

Alexion Pharmaceuticals, Inc.: Overview

Alexion Pharmaceuticals, Inc.: Key Facts

Alexion Pharmaceuticals, Inc.: Key Employees

Alexion Pharmaceuticals, Inc.: Key Employee Biographies

Alexion Pharmaceuticals, Inc.: Major Products and Services

Alexion Pharmaceuticals, Inc.: Company History

Alexion Pharmaceuticals, Inc.: Management Statement

Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries

Alexion Pharmaceuticals, Inc.: Key Competitors

Alexion Pharmaceuticals, Inc.: Company Analysis

Alexion Pharmaceuticals, Inc.: Business Description

Alexion Pharmaceuticals, Inc.: SWOT Analysis

Alexion Pharmaceuticals, Inc.: SWOT Overview

Alexion Pharmaceuticals, Inc.: Strengths

Alexion Pharmaceuticals, Inc.: Weaknesses

Alexion Pharmaceuticals, Inc.: Opportunities

Alexion Pharmaceuticals, Inc.: Threats

Alexion Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Alexion Pharmaceuticals, Inc.: Financial Deals Overview

Alexion Pharmaceuticals, Inc.: Targets and Partners

Alexion Pharmaceuticals, Inc.: Top Deals 2013 - 2017YTD*

Alexion Pharmaceuticals, Inc.: Advisors

Alexion Pharmaceuticals, Inc.: Top Legal Advisors

Alexion Pharmaceuticals, Inc.: Top Financial Advisors

Alexion Pharmaceuticals, Inc.: Mergers and Acquisitions

Alexion Pharmaceuticals, Inc.: Partnership

Alexion Pharmaceuticals, Inc.: Recent Developments

Alexion Pharmaceuticals, Inc.: News and Events Summary

Alexion Pharmaceuticals, Inc.: Corporate Governance

Alexion Pharmaceuticals, Inc.: Financial Performance

Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals

Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events

Alexion Pharmaceuticals, Inc.: Research & Development

Alexion Pharmaceuticals, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About MarketLine

List of Tables

List of Tables

Table 1: Alexion Pharmaceuticals, Inc.: Key Facts

Table 2: Alexion Pharmaceuticals, Inc.: Key Employees

Table 3: Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries ...

List of Tables

Table 1: Alexion Pharmaceuticals, Inc.: Key Facts

Table 2: Alexion Pharmaceuticals, Inc.: Key Employees

Table 3: Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Alexion Pharmaceuticals, Inc.: Key Competitors

Table 5: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)

Table 6: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)

Table 7: Alexion Pharmaceuticals, Inc.: Targets and Partners

Table 8: Alexion Pharmaceuticals, Inc.: Top Deals 2013 - 2017YTD*

Table 9: Alexion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)

Table 10: Alexion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 11: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)

Table 12: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2013 - YTD*2017)

Table 13: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)

Table 14: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)

Table 15: Alexion Pharmaceuticals, Inc.: News and Events Summary

Table 16: Alexion Pharmaceuticals, Inc.: Corporate Governance

Table 17: Alexion Pharmaceuticals, Inc.: Financial Performance

Table 18: Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals

Table 19: Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 20: Alexion Pharmaceuticals, Inc.: Research & Development

Table 21: Alexion Pharmaceuticals, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)

Figure 2: Alexion Pharmaceuticals, Inc.: M&A Average ...

List of Figures

Figure 1: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)

Figure 2: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)

Figure 3: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)

Figure 4: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2013 - YTD*2017)

Figure 5: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)

Figure 6: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports